当代左心室辅助装置治疗作为移植的桥梁或替代方案
Jacinthe Boulet1, Mauro R B Wanderley, Mandeep R Mehra
1Center for Advanced Heart Disease, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Transplantation
|October 24, 2023
概括
左心室辅助器件 (LVADs) 对晚期心力衰竭患者提供显著的生存益处和改善功能能力,作为通往心脏移植或目的地治疗的桥梁.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 心脏衰竭管理的管理
背景情况:
- 左心室辅助器件 (LVAD) 从桥梁到心脏移植 (HT) 演变为高级心力衰竭的既定替代方案.
- 当代的LVAD显著延长了严重心力衰竭患者的生存期,并改善了患者的功能能力.
研究的目的:
- 审查LVADs的演变和结果.
- 讨论LVADs的免疫和感染相关影响.
- 探索LVAD在心肌恢复和HT分配政策中的作用.
主要方法:
- 对LVADs的历史数据和当代结果的审查.
- 对免疫和感染相关并发症的分析.
- 检查LVAD对心脏移植和心肌恢复的影响.
主要成果:
- 当代LVAD的平均存活时间超过5年,功能能力翻倍.
- 在精选的患者中,LVADs有助于心肌恢复,允许装置扩展.
- 通过LVAD将HT与HT相结合,显示出优异的生存率,在5年内成功率为80%.
结论:
- LVAD是晚期心力衰竭的重要疗法,提供生存益处和改善生活质量.
- 在将患者连接到心脏移植或使心肌恢复方面,LVAD发挥着至关重要的作用.
- 未来的前景包括新型设备开发和优化HT分配政策.
相关概念视频
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11


